According to Latest Research, the global market for ADC Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China ADC Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States ADC Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Breast Cancer grew percent to account for percent of the total market sales, and Lymphoma grew percent.
This report studies and analyses global ADC Drug status and future trends, helps the client to determine the ADC Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for ADC Drug, and provides market size (in K Bottles & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global ADC Drug market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Bottles)
(2) Global ADC Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Bottles)
(3) China ADC Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Bottles)
(4) Global ADC Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global ADC Drug key producing regions, capacity, production, and year over year growth
(6) ADC Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Pfizer Inc.
Seagen
Roche
AstraZeneca
RemeGen Co., Ltd.
Rakuten Medical
Gilead(Immunomedics)
ADC Therapeutics
Market segment by Type, covers
First Generation ADC Drug
Second Generation ADC Drug
Third Generation ADC Drug
Market segment by Application, can be divided into
Breast Cancer
Lymphoma
Leukemia
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe ADC Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global ADC Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China ADC Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of ADC Drug, percent & CAGR, 2018-2029
Chapter 5: ADC Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 ADC Drug Definition
1.2 Global ADC Drug Market Size and Forecast
1.2.1 By Consumption Value, Global ADC Drug Market Size,2018-2029
1.2.2 By Sales Quantity, Global ADC Drug Market Size,2018-2029
1.2.3 Global ADC Drug Average Selling Price (ASP),2018-2029
1.3 China ADC Drug Market Size and Forecast
1.3.1 By Consumption Value, China ADC Drug Market Size,2018-2029
1.3.2 By Sales Quantity, China ADC Drug Market Size,2018-2029
1.3.3 China ADC Drug Average Selling Price (ASP), 2018-2029
1.4 Share of China ADC Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China ADC Drug Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China ADC Drug Market Share in Global, 2018-2029
1.4.3 ADC Drug Market Size: China VS Global, 2018-2029
1.5 ADC Drug Market Dynamics
1.5.1 ADC Drug Market Drivers
1.5.2 ADC Drug Market Restraints
1.5.3 ADC Drug Industry Trends
1.5.4 ADC Drug Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of ADC Drug, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of ADC Drug, Global Market Share by Company, 2018-2023
2.3 ADC Drug Average Selling Price (ASP) by Company, 2018-2023
2.4 Global ADC Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global ADC Drug Concentration Ratio
2.6 Global ADC Drug Mergers & Acquisitions, Expansion Plans
2.7 Global ADC Drug Manufacturers Product Type
2.8 Head Office and ADC Drug Production Site of Key Manufacturer
2.9 ADC Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of ADC Drug, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of ADC Drug, China Market Share by Company, 2018-2023
3.3 China ADC Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global ADC Drug Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global ADC Drug Capacity by Region
4.3 Global ADC Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global ADC Drug Production by Region, 2018-2029
4.5 Global ADC Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 ADC Drug Industry Chain
5.2 ADC Drug Upstream Analysis
5.2.1 ADC Drug Core Raw Materials
5.2.2 Main Manufacturers of ADC Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 ADC Drug Production Mode
5.6 ADC Drug Procurement Model
5.7 ADC Drug Industry Sales Model and Sales Channels
5.7.1 ADC Drug Sales Model
5.7.2 ADC Drug Typical Distributors
6 Sights by Type
6.1 ADC Drug Classification
6.1.1 First Generation ADC Drug
6.1.2 Second Generation ADC Drug
6.1.3 Third Generation ADC Drug
6.2 By Type, Global ADC Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global ADC Drug Consumption Value, 2018-2029
6.4 By Type, Global ADC Drug Sales Quantity, 2018-2029
6.5 By Type, Global ADC Drug Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 ADC Drug Segment by Application
7.1.1 Breast Cancer
7.1.2 Lymphoma
7.1.3 Leukemia
7.1.4 Other
7.2 By Application, Global ADC Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global ADC Drug Consumption Value, 2018-2029
7.4 By Application, Global ADC Drug Sales Quantity, 2018-2029
7.5 By Application, Global ADC Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global ADC Drug Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global ADC Drug Consumption Value, 2018-2029
8.3 By Region, Global ADC Drug Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America ADC Drug & Forecasts, 2018-2029
8.4.2 By Country, North America ADC Drug Market Size Market Share
8.5 Europe
8.5.1 Europe ADC Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe ADC Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific ADC Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific ADC Drug Market Size Market Share
8.7 South America
8.7.1 South America ADC Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America ADC Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global ADC Drug Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global ADC Drug Consumption Value, 2018-2029
9.3 By Country, Global ADC Drug Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. ADC Drug Market Size, 2018-2029
9.4.2 By Type, U.S. ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe ADC Drug Market Size, 2018-2029
9.5.2 By Type, Europe ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China ADC Drug Market Size, 2018-2029
9.6.2 By Type, China ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan ADC Drug Market Size, 2018-2029
9.7.2 By Type, Japan ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea ADC Drug Market Size, 2018-2029
9.8.2 By Type, South Korea ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia ADC Drug Market Size, 2018-2029
9.9.2 By Type, Southeast Asia ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India ADC Drug Market Size, 2018-2029
9.10.2 By Type, India ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa ADC Drug Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa ADC Drug Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa ADC Drug Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Pfizer Inc. ADC Drug Models, Specifications, and Application
10.1.3 Pfizer Inc. ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Inc. Company Profile and Main Business
10.1.5 Pfizer Inc. Recent Developments
10.2 Seagen
10.2.1 Seagen Company Information, Head Office, Market Area, and Industry Position
10.2.2 Seagen ADC Drug Models, Specifications, and Application
10.2.3 Seagen ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Seagen Company Profile and Main Business
10.2.5 Seagen Recent Developments
10.3 Roche
10.3.1 Roche Company Information, Head Office, Market Area, and Industry Position
10.3.2 Roche ADC Drug Models, Specifications, and Application
10.3.3 Roche ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Roche Company Profile and Main Business
10.3.5 Roche Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.4.2 AstraZeneca ADC Drug Models, Specifications, and Application
10.4.3 AstraZeneca ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 RemeGen Co., Ltd.
10.5.1 RemeGen Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.5.2 RemeGen Co., Ltd. ADC Drug Models, Specifications, and Application
10.5.3 RemeGen Co., Ltd. ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 RemeGen Co., Ltd. Company Profile and Main Business
10.5.5 RemeGen Co., Ltd. Recent Developments
10.6 Rakuten Medical
10.6.1 Rakuten Medical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Rakuten Medical ADC Drug Models, Specifications, and Application
10.6.3 Rakuten Medical ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Rakuten Medical Company Profile and Main Business
10.6.5 Rakuten Medical Recent Developments
10.7 Gilead(Immunomedics)
10.7.1 Gilead(Immunomedics) Company Information, Head Office, Market Area, and Industry Position
10.7.2 Gilead(Immunomedics) ADC Drug Models, Specifications, and Application
10.7.3 Gilead(Immunomedics) ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Gilead(Immunomedics) Company Profile and Main Business
10.7.5 Gilead(Immunomedics) Recent Developments
10.8 ADC Therapeutics
10.8.1 ADC Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.8.2 ADC Therapeutics ADC Drug Models, Specifications, and Application
10.8.3 ADC Therapeutics ADC Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 ADC Therapeutics Company Profile and Main Business
10.8.5 ADC Therapeutics Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. ADC Drug Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. ADC Drug Market Restraints
Table 3. ADC Drug Market Trends
Table 4. ADC Drug Industry Policy
Table 5. Global ADC Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global ADC Drug Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global ADC Drug Sales Quantity by Company, (2018-2023) & (K Bottles), Ranked Based on Sales in 2022
Table 8. Global ADC Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global ADC Drug Average Selling Price (ASP) by Company, (2018-2023) & (US$/Bottle)
Table 10. Global ADC Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global ADC Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global ADC Drug Manufacturers Product Type
Table 13. Head Office and ADC Drug Production Site of Key Manufacturer
Table 14. ADC Drug Capacity of Major Manufacturers and Future Plan
Table 15. China ADC Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China ADC Drug Sales Quantity by Company, (2018-2023) & (K Bottles), Ranked Based on Sales in 2022
Table 17. China ADC Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global ADC Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Bottles)
Table 19. Global ADC Drug Production by Region, 2018-2023, (K Bottles)
Table 20. Global ADC Drug Production Forecast by Region, 2024-2029, (K Bottles)
Table 21. Global Key Players of ADC Drug Upstream (Raw Materials)
Table 22. Global ADC Drug Typical Customers
Table 23. ADC Drug Typical Distributors
Table 24. By Type, Global ADC Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global ADC Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global ADC Drug Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global ADC Drug Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Table 29. By Country, Global ADC Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global ADC Drug Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global ADC Drug Consumption Value Market Share, 2018-2029
Table 32. By Country, Global ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Table 33. By Country, Global ADC Drug Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Inc. Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Inc. ADC Drug Models, Specifications, and Application
Table 36. Pfizer Inc. ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 37. Pfizer Inc. Company Profile and Main Business
Table 38. Pfizer Inc. Recent Developments
Table 39. Seagen Company Information, Head Office, Market Area, and Industry Position
Table 40. Seagen ADC Drug Models, Specifications, and Application
Table 41. Seagen ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 42. Seagen Company Profile and Main Business
Table 43. Seagen Recent Developments
Table 44. Roche Company Information, Head Office, Market Area, and Industry Position
Table 45. Roche ADC Drug Models, Specifications, and Application
Table 46. Roche ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 47. Roche Company Profile and Main Business
Table 48. Roche Recent Developments
Table 49. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 50. AstraZeneca ADC Drug Models, Specifications, and Application
Table 51. AstraZeneca ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 52. AstraZeneca Company Profile and Main Business
Table 53. AstraZeneca Recent Developments
Table 54. RemeGen Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 55. RemeGen Co., Ltd. ADC Drug Models, Specifications, and Application
Table 56. RemeGen Co., Ltd. ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 57. RemeGen Co., Ltd. Company Profile and Main Business
Table 58. RemeGen Co., Ltd. Recent Developments
Table 59. Rakuten Medical Company Information, Head Office, Market Area, and Industry Position
Table 60. Rakuten Medical ADC Drug Models, Specifications, and Application
Table 61. Rakuten Medical ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 62. Rakuten Medical Company Profile and Main Business
Table 63. Rakuten Medical Recent Developments
Table 64. Gilead(Immunomedics) Company Information, Head Office, Market Area, and Industry Position
Table 65. Gilead(Immunomedics) ADC Drug Models, Specifications, and Application
Table 66. Gilead(Immunomedics) ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 67. Gilead(Immunomedics) Company Profile and Main Business
Table 68. Gilead(Immunomedics) Recent Developments
Table 69. ADC Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 70. ADC Therapeutics ADC Drug Models, Specifications, and Application
Table 71. ADC Therapeutics ADC Drug Sales Quantity (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin, 2018-2023
Table 72. ADC Therapeutics Company Profile and Main Business
Table 73. ADC Therapeutics Recent Developments
List of Figures
Figure 1. ADC Drug Picture
Figure 2. Global ADC Drug Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global ADC Drug Sales Quantity, (K Bottles) & (2018-2029)
Figure 4. Global ADC Drug Average Selling Price (ASP), (2018-2029) & (US$/Bottle)
Figure 5. China ADC Drug Consumption Value, (US$ million) & (2018-2029)
Figure 6. China ADC Drug Sales Quantity (K Bottles) & (2018-2029)
Figure 7. China ADC Drug Average Selling Price (ASP), (US$/Bottle) & (2018-2029)
Figure 8. By Consumption Value, China ADC Drug Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China ADC Drug Market Share of Global, 2018-2029
Figure 10. Global ADC Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China ADC Drug Key Participants, Market Share, 2022
Figure 12. Global ADC Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global ADC Drug Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global ADC Drug Production Market Share & Forecast by Region, 2018-2029
Figure 15. ADC Drug Industry Chain
Figure 16. ADC Drug Procurement Model
Figure 17. ADC Drug Sales Model
Figure 18. ADC Drug Sales Channels, Direct Sales, and Distribution
Figure 19. First Generation ADC Drug
Figure 20. Second Generation ADC Drug
Figure 21. Third Generation ADC Drug
Figure 22. By Type, Global ADC Drug Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global ADC Drug Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 25. By Type, Global ADC Drug Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global ADC Drug Average Selling Price (ASP), 2018-2029, (US$/Bottle)
Figure 27. Breast Cancer
Figure 28. Lymphoma
Figure 29. Leukemia
Figure 30. Other
Figure 31. By Application, Global ADC Drug Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global ADC Drug Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 34. By Application, Global ADC Drug Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global ADC Drug Average Selling Price (ASP), 2018-2029, (US$/Bottle)
Figure 36. By Region, Global ADC Drug Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global ADC Drug Sales Quantity Market Share, 2018-2029
Figure 38. North America ADC Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America ADC Drug Consumption Value Market Share, 2022
Figure 40. Europe ADC Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe ADC Drug Consumption Value Market Share, 2022
Figure 42. Asia Pacific ADC Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific ADC Drug Consumption Value Market Share, 2022
Figure 44. South America ADC Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America ADC Drug Consumption Value Market Share, 2022
Figure 46. Middle East & Africa ADC Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 48. By Type, U.S. ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 51. By Type, Europe ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 53. China ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 54. By Type, China ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 57. By Type, Japan ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 60. By Type, South Korea ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 63. By Type, Southeast Asia ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 65. India ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 66. By Type, India ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa ADC Drug Sales Quantity, 2018-2029, (K Bottles)
Figure 69. By Type, Middle East & Africa ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa ADC Drug Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|